Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Sales of resin additives, including flame retardants and antioxidants, were weak, while sales of PVC stabilizers were strong. Semiconductor materials performed well, including semiconductor lithography materials, but fixed costs increased due to additional research and development personnel and the construction of new production plants. Environmental Materials performed well, driven by lubricant additives and specialty epoxy resins. Food products, including high-function kneading materials, remained firm, while sales of shortening and margarine products were weak in China. The Life Science business benefited from strong sales of agricultural chemicals in Europe, North America and Japan.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥416,563 million (YoY +2.3%) |
| Operating profit | ¥41,614 million (YoY +1.5%) |
| Ordinary income | ¥42,772 million (YoY +8.7%) |
| Profit attributable to owners of the parent | ¥27,866 million (YoY +11.4%) |
| Net income per share | ¥277.95 |
| Operating Margin | 10.0％ |
| Equity ratio | End of the current fiscal period 56.0％ / End of previous period 54.6％ |
| Total assets | ¥559,987 million |
| Net assets | ¥371,572 million |
| Cash flows from operating activities | ¥40,612 million |
| Cash flows from investing activities | ¥-30,078 million |
| Cash flows from financing activities | ¥-35,301 million |
| Cash and cash equivalents at end of period | ¥87,884 million |
| Full-year earnings forecast | Net Sales ¥453,000 million (YoY +8.7%) / Operating profit ¥46,800 million (YoY +12.5%) / Ordinary income ¥46,600 million (YoY +8.9%) / Net income ¥28,800 million (YoY +3.4%) |
| Annual Dividend Forecast | ¥112 per share → ¥120 per share（+7.1%） |
| Payout ratio | 40.8％ |
| Shareholder Return Policy | Dividend payout ratio of at least 40% |
| Segment revenue | Chemicals Business 2,148 Hundreds of millions of yen (YoY -1.7%), Food Business 830 Hundreds of millions of yen (YoY +0.6%), Life Sciences Business 1,117 Hundreds of millions of yen (YoY +11.8%) |
| Segment profit | Chemicals Business 263 Hundreds of millions of yen (YoY -6.0%), Food Business 43 Hundreds of millions of yen (YoY -0.6%), Life Sciences Business 98 Hundreds of millions of yen (YoY +26.4%) |
| Depreciation and amortization | ¥18,835 million |
| Impairment loss | ¥381 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥125 million, Gain on sale of investment securities ¥2,065 million, Gain on sale of shares in an affiliated company ¥323 million / Extraordinary loss Loss on disposal of fixed assets ¥946 million, Impairment Losses ¥381 million, Settlement Payments ¥1,072 million, Environmental Measures Expense ¥6 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Not disclosed / Excluded Not disclosed / Company name Not disclosed / Material changes No |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 103,768,142 |
| Treasury Shares at Period-End | 5,910,048 |
| Factors Behind Changes in Business Performance | Sales of resin additives, including flame retardants and antioxidants, were weak, while sales of PVC stabilizers were strong. Semiconductor materials performed well, including semiconductor lithography materials, but fixed costs increased due to additional research and development personnel and the construction of new production plants. Environmental Materials performed well, driven by lubricant additives and specialty epoxy resins. Food products, including high-function kneading materials, remained firm, while sales of shortening and margarine products were weak in China. The Life Science business benefited from strong sales of agricultural chemicals in Europe, North America and Japan. |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.During the fiscal year, sales of agricultural chemicals in Europe, North America and Japan were strong in the Life Science business, while sales of lubricant additives and specialty epoxy resins increased in Environmental Materials. In Chemicals, however, sales of resin additives were weak and the business incurred upfront investment costs for semiconductor materials. For the next fiscal year, the company expects sales of semiconductor materials, lubricant additives for automobiles, high-function food products and agricultural chemicals to expand.